Cook® Medical Introduces Biodesign® Duraplasty Graft To Otolaryngologists For Dura Mater Repair

Source : BUSINESS WIRE

BLOOMINGTON, Ind.--()--Cook Medical has launched a new treatment option for otolaryngologists (ear, nose and throat specialists) who repair the dura mater following cerebrospinal fluid (CSF) leaks at the base of the skull. Cook’s Biodesign® Duraplasty Graft is the latest Biodesign product from Cook Medical’s Otolaryngology—Head and Neck Surgery (OHNS) clinical division.

A dura substitute, the Biodesign Duraplasty Graft is used to repair the dura mater and prevent CSF leaks following surgical procedures at the skull base (e.g. tumor resection). In other cases, the graft may be used to treat existing CSF leaks such as those resulting from trauma or sinus surgery at the skull base.

During the repair procedure, the Biodesign graft is easy to manipulate, because of its advanced handling characteristics. The graft doesn’t swell when hydrated and doesn’t fold onto itself. The graft can be placed with or without sutures and can achieve a strong seal,1 so it provides a well-balanced treatment option for dura mater repair at the skull base. Another benefit of Biodesign is that it reduces the need to harvest tissue from other parts of the body for use in the repair.

“I started using Biodesign because I found it easier to handle during the endoscopic repair than competing products,” said Bradford A. Woodworth, M.D., director of otolaryngology research at the University of Alabama at Birmingham, in a letter to the U.S. Food and Drug Administration in which he evaluated the new device. "Although not directly measured, [I] feel it contributes to faster graft placement and increased operative speed."

“Biodesign’s proven tissue repair technology works in different grafting procedures,” said Thomas Cherry, R.N., OHNS global clinical division leader for Cook Medical. “We’re excited to introduce the device to otolaryngologists and expand OHNS’s Biodesign line. Because of Biodesign’s excellent handling characteristics, physicians can secure the Biodesign graft during skull-base dura mater reconstruction with or without suturing.”

Cook’s proprietary Biodesign graft technology is derived from a natural material. It is designed to enable physicians to easily manipulate and secure the graft. Biodesign has been used since 1998 to treat more than 750,000 patients worldwide. Biodesign is non-dermis based and non-cross-linked so that the body can remodel it into strong, well-vascularized tissue.

Note: Dr. Bradford Woodworth is a paid consultant to Cook Medical with respect to its medical devices.

About Cook Medical

Since 1963 Cook Medical has worked closely with physicians to develop technologies that eliminate the need for open surgery. Today we are combining medical devices, biologic materials and cellular therapies to help the world's healthcare systems deliver better outcomes more efficiently. We have always remained family-owned so that we have the freedom to focus on what we care about: patients, our employees and our communities. Find out more at www.cookmedical.com, and for the latest news, follow us on Twitter, Facebook and LinkedIn. Follow Cook OHNS @CookOHNS.

1 Benjjani GK, Zabramski J; Durasis Study Group. Safety and efficacy of the porcine small intestinal submucosa dural substitute: results of a prospective multicenter study and literature review. J Neurosurg. 2007;106(6):1028-1033.

  • <<
  • >>

Articles List

  • Keep Tabs on T-Cell Proliferation with These Flow Cytometry Techniques

    Keep Tabs on T-Cell Proliferation with These Flow Cytometry Techniques

    Cell proliferation is often the principle readout of T-cell stimulation. There are myriad flow cytometric methods researchers can use to see if cells are or have been replicating. Here we discuss the power and pitfalls of such assays.
  • Listen in on Cellular Chatter with These Exosome-Analysis Tools

    Listen in on Cellular Chatter with These Exosome-Analysis Tools

    When it comes to bodily fluids, we tend to think of them as homogeneous. But that isn’t precisely true. Yes, protein (and nucleic acids) do float free in serum, urine and other samples. But some biomolecules are encapsulated within lipid-bound compartments called exosomes or vesicles, and researchers increasingly are mining these as rich veins of molecular candidates for biomarker discovery.

Disqus Comments